Type 2 diabetes and cause-specific mortality in Mexico City: a Mendelian randomisation analysis
EMBERSON J. et al, (2025), The Lancet Regional Health - Americas
Comparative studies of 2168 plasma proteins measured by two affinity-based platforms in 4000 Chinese adults.
Wang B. et al, (2025), Nat Commun, 16
Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
EMPA-KIDNEY Collaborative Group None. et al, (2025), N Engl J Med, 392, 777 - 787
Risk prediction of ischemic heart disease using plasma proteomics, conventional risk factors and polygenic scores in Chinese and European adults.
Mazidi M. et al, (2024), Eur J Epidemiol, 39, 1229 - 1240
Blood Pressure, eGFR, and Kidney Mortality in Mexico: A Prospective Study of 150,000 Adults
Zhu D. et al, (2024), Journal of the American Society of Nephrology, 35
Prospective evaluation of the relevance of Epstein-Barr virus antibodies for early detection of nasopharyngeal carcinoma in Chinese adults.
Yang L. et al, (2024), Int J Epidemiol, 53
PCSK9 genetic variants and risk of vascular and non-vascular diseases in Chinese and UK populations.
Holmes MV. et al, (2024), Eur J Prev Cardiol, 31, 1015 - 1025
Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.
Yao P. et al, (2024), Diabetes Care, 47, 1012 - 1019
Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.
Kartsonaki C. et al, (2024), Int J Cancer, 154, 1423 - 1432
A common NFKB1 variant detected through antibody analysis in UK Biobank predicts risk of infection and allergy.
Chong AY. et al, (2024), Am J Hum Genet, 111, 295 - 308
Author Correction: Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Ziyatdinov A. et al, (2024), Nature, 626
Genome-wide SNP-sex interaction analysis of susceptibility to idiopathic pulmonary fibrosis.
Leavy OC. et al, (2024), medRxiv
A wide landscape of morbidity and mortality risk associated with marital status in 0.5 million Chinese men and women: a prospective cohort study.
Xiao M. et al, (2024), Lancet Reg Health West Pac, 42
Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial.
EMPA-KIDNEY Collaborative Group None., (2024), Lancet Diabetes Endocrinol, 12, 39 - 50
Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial.
EMPA-KIDNEY Collaborative Group None., (2024), Lancet Diabetes Endocrinol, 12, 51 - 60
Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease.
Mazidi M. et al, (2023), J Am Coll Cardiol, 82, 1906 - 1920
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial.
Wijesurendra RS. et al, (2023), Eur Heart J
Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults.
Yao P. et al, (2023), Eur J Epidemiol, 38, 1089 - 1103
Genotyping, sequencing and analysis of 140,000 adults from Mexico City.
Ziyatdinov A. et al, (2023), Nature, 622, 784 - 793